Zobrazeno 1 - 10
of 22
pro vyhledávání: '"L F A Wessels"'
Publikováno v:
Open Biology, Vol 8, Iss 8 (2018)
Cancer is a complex disease in which cells progressively accumulate mutations disrupting their cellular processes. A fraction of these mutations drive tumourigenesis by affecting oncogenes or tumour suppressor genes, but many mutations are passengers
Externí odkaz:
https://doaj.org/article/e2ee2d21a73a49ceb0f3858c483add14
Autor:
L. F. A. Wessels, Amina Zoubeidi, Wilbert Zwart, Simon Linder, Suzan Stelloo, Nicholas Lack, M. Alkemade, Joyce Sanders, J. De Jong, A.M. Bergman, Marlous Hoogstraat, Elise Bekers, H.A. De Barros, Claudia Giambartolomei, Ji Hae Seo, Karianne Schuurman, Yongsoo Kim, L. M. Butler, Bogdan Pasaniuc, Roel J.C. Kluin, Mathew Freedman, H.G. Van Der Poel
In prostate cancer, androgen receptor (AR)-targeting agents are very effective in various stages of the disease. However, therapy resistance inevitably occurs and little is known about how tumor cells adapt to bypass AR suppression. Here, we performe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8805d7449368eaf917ef10c3f7c23d36
https://doi.org/10.1101/2021.11.02.21265806
https://doi.org/10.1101/2021.11.02.21265806
Autor:
Srinivasan Yegnasubramanian, Matthew L. Freedman, Angelo M. De Marzo, Andries M. Bergman, Yanyun Zhu, Michael C. Haffner, Wilbert Zwart, Jonathan W. Simons, L. F. A. Wessels, Tracy Jones, Tesa M. Severson, William G. Nelson
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d1be595681131bd3f374f40ee08d3b0
https://doi.org/10.1002/1878-0261.12923/v2/response1
https://doi.org/10.1002/1878-0261.12923/v2/response1
Autor:
Andries M. Bergman, Eider Valle-Encinas, Seiwon Laura Chang, Karianne Schuurman, João Lobo, Rui Henrique, Felix Y. Feng, Carmen Jerónimo, Suzan Stelloo, Wilbert Zwart, Ekaterina Nevedomskaya, Oscar Krijgsman, Daniel S. Peeper, L. F. A. Wessels, Yongsoo Kim
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-12 (2018)
Nature Communications, 9(1):4900. Nature Publishing Group UK
Nature Communications, 9(1)
Nature Communications, 9(1):4900. Nature Publishing Group
Nature Communications
Stelloo, S, Nevedomskaya, E, Kim, Y, Schuurman, K, Valle-Encinas, E, Lobo, J, Krijgsman, O, Peeper, D S, Chang, S L, Feng, F Y C, Wessels, L F A, Henrique, R, Jerónimo, C, Bergman, A M & Zwart, W 2018, ' Integrative epigenetic taxonomy of primary prostate cancer ', Nature Communications, vol. 9, no. 1, 4900 . https://doi.org/10.1038/s41467-018-07270-2
Nature Communications, 9(1):4900. Nature Publishing Group UK
Nature Communications, 9(1)
Nature Communications, 9(1):4900. Nature Publishing Group
Nature Communications
Stelloo, S, Nevedomskaya, E, Kim, Y, Schuurman, K, Valle-Encinas, E, Lobo, J, Krijgsman, O, Peeper, D S, Chang, S L, Feng, F Y C, Wessels, L F A, Henrique, R, Jerónimo, C, Bergman, A M & Zwart, W 2018, ' Integrative epigenetic taxonomy of primary prostate cancer ', Nature Communications, vol. 9, no. 1, 4900 . https://doi.org/10.1038/s41467-018-07270-2
The Androgen Receptor (AR) is the key-driving transcription factor in prostate cancer, tightly controlled by epigenetic regulation. To date, most epigenetic profiling has been performed in cell lines or limited tissue samples. Here, to comprehensivel
Autor:
Charles L. Sawyers, Emile E. Voest, Jeremy Lewin, Lillian L. Siu, Robyn L. Ward, Mark Lawler, Anamaria A. Camargo, Mao Mao, L. F. A. Wessels, Rachel G. Liao, Fabien Calvo, Fabrice Andre, Bartha Maria Knoppers, Bin Tean Teh, Daniel J. Vis
Publikováno v:
Vis, D J, Lewin, J, Liao, R G, Mao, M, Andre, F, Ward, R L, Calvo, F, Teh, B T, Camargo, A A, Knoppers, B M, Sawyers, C L, Wessels, L F A, Lawler, M, Siu, L L, Voest, E & Clinical Working Group of the Global Alliance for Genomics and Health 2017, ' Towards a global cancer knowledge network: dissecting the current international cancer genomic sequencing landscape ' Annals of Oncology, vol. 28, no. 5, pp. 1145-1151 . DOI: 10.1093/annonc/mdx037
Annals of Oncology
Annals of Oncology
Background: While next generation sequencing has enhanced our understanding of the biological basis of malignancy, current knowledge on global practices for sequencing cancer samples is limited. To address this deficiency, we developed a survey to pr
Publikováno v:
Annals of Oncology. 31:S274
Autor:
Simak Ali, Sander Canisius, Koen D. Flach, Ajit Jadhav, Wilbert Zwart, Alexey V. Zakharov, Theresa E. Hickey, Jelle Wesseling, Anton Simeonov, Marja Nieuwland, Wayne D. Tilley, Dorjbal Dorjsuren, Mark Opdam, David M. Wilson, Sabine C. Linn, Hetal Patel, L. F. A. Wessels, Roel J.C. Kluin, Manikandan Periyasamy
Publikováno v:
Endocrine Abstracts.
Autor:
Liesbeth Hoekman, T Mirza, Onno B. Bleijerveld, Wilbert Zwart, L. F. A. Wessels, Suzan Stelloo, Yongsoo Kim, W.M. van Weerden, Andries M. Bergman, A F M Altelaar, Ekaterina Nevedomskaya
Publikováno v:
Oncogene, 37(3), 313-322. Nature Publishing Group
Stelloo, S, Nevedomskaya, E, Kim, Y, Hoekman, L, Bleijerveld, O B, Mirza, T, Wessels, L F A, Van Weerden, W M, Altelaar, A F M, Bergman, A M & Zwart, W 2018, ' Endogenous androgen receptor proteomic profiling reveals genomic subcomplex involved in prostate tumorigenesis ', Oncogene, vol. 37, no. 3, pp. 313-322 . https://doi.org/10.1038/onc.2017.330
Oncogene, 37. Nature Publishing Group
Stelloo, S, Nevedomskaya, E, Kim, Y, Hoekman, L, Bleijerveld, O B, Mirza, T, Wessels, L F A, Van Weerden, W M, Altelaar, A F M, Bergman, A M & Zwart, W 2018, ' Endogenous androgen receptor proteomic profiling reveals genomic subcomplex involved in prostate tumorigenesis ', Oncogene, vol. 37, no. 3, pp. 313-322 . https://doi.org/10.1038/onc.2017.330
Oncogene, 37. Nature Publishing Group
Androgen receptor (AR) is a key player in prostate cancer development and progression. Here we applied immunoprecipitation mass spectrometry of endogenous AR in LNCaP cells to identify components of the AR transcriptional complex. In total, 66 known
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2429f5480396141ca15ad7224d72aa2
https://dspace.library.uu.nl/handle/1874/428130
https://dspace.library.uu.nl/handle/1874/428130
Autor:
Evert Bosdriesz, Bounova G, Magali Michaut, de Ruiter, Daniel J. Vis, Nanne Aben, Yongsoo Kim, L. F. A. Wessels
Combining anti-cancer drugs has the potential to increase treatment efficacy. Because patient responses to drug combinations are highly variable, predictive biomarkers of synergy are required to identify which patients are likely to benefit from a dr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29a76c98a33095a3e90495de53f8edc8